Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Looking to boost your income quickly? Discover ways to earn money fast on short notice with these effective ideas.
20,646 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Gas prices swung in 2026 amid Middle East tensions, lifting refining margins. This article identifies the stocks pois...
SpaceX is attracting renewed investor interest as revenue streams expand beyond launches. With Starlink, NASA deals, ...
Investors face a stark choice in 2026: back an infrastructure-focused sand and logistics player in the Permian or bac...
Windermere Real Estate has tapped Diana Wall to lead growth across its independent brokerage network, underscoring a ...
Bitcoin has shed about half its value from October peaks, testing investor nerves. Retail buyers on Coinbase persist,...
Anthropic's $200 million DoD contract is under scrutiny after reports about Claude's deployment in a January raid. Th...
A pro-Ripple lawyer’s critique of a potential Sam Bankman-Fried pardon is shaping XRP traders’ views as price targets...
In a long, closely watched State of the Union address, President Trump steered clear of tariff refunds and trade reme...
This article breaks down Summit Hotel (Inn) earnings, translating quarterly results into actionable insights for inve...
In 2025, Interactive Brokers stayed focused on the engine that powers long-term success: scale, discipline, and momen...
Tesla’s foray into robotics and AI promises upside, but it also introduces new risks for shareholders. This guide bre...